16 related articles for article (PubMed ID: 38461692)
1. Increased cellularity of tumor-encased native vessels in prostate carcinoma is a marker for tumor progression.
Garcia FU; Taylor CA; Hou JS; Rukstalis DB; Stearns ME
Mod Pathol; 2000 Jul; 13(7):717-22. PubMed ID: 10912929
[TBL] [Abstract][Full Text] [Related]
2. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
Zhou M; Hayasaka S; Taylor JM; Shah R; Proverbs-Singh T; Manley S; Rubin MA
J Urol; 2001 Dec; 166(6):2193-7. PubMed ID: 11696734
[TBL] [Abstract][Full Text] [Related]
3. Diffusion Restriction Comparison between Gleason 4 Fused Glands and Cribriform Glands within Patient Using Whole-Mount Prostate Pathology as Ground Truth.
Duenweg SR; Fang X; Bobholz SA; Lowman AK; Brehler M; Kyereme F; Iczkowski KA; Jacobsohn KM; Banerjee A; LaViolette PS
Tomography; 2022 Mar; 8(2):635-643. PubMed ID: 35314630
[TBL] [Abstract][Full Text] [Related]
4. Prediction of pathological stage in patients with clinical stage T1c prostate cancer: the new challenge.
Veltri RW; Miller MC; Mangold LA; O'Dowd GJ; Epstein JI; Partin AW
J Urol; 2002 Jul; 168(1):100-4. PubMed ID: 12050500
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Histomorphometric Features of Prostate Cancer Predict Patients Who Biochemically Recur Following Prostatectomy.
Duenweg SR; Brehler M; Lowman AK; Bobholz SA; Kyereme F; Winiarz A; Nath B; Iczkowski KA; Jacobsohn KM; LaViolette PS
Lab Invest; 2023 Dec; 103(12):100269. PubMed ID: 37898290
[TBL] [Abstract][Full Text] [Related]
6. Morphologic features of prostate cancer-encased native vessels: An image analysis study.
Fernandez Gonzalez De La Vega C; Duenweg S; Jain P; Rubenstein SI; Bobholz S; Barrett MJ; LaViolette PS; Iczkowski KA
Pathol Res Pract; 2024 Apr; 256():155239. PubMed ID: 38461692
[TBL] [Abstract][Full Text] [Related]
7. Should the Gleason grading system for prostate cancer be modified to account for high-grade tertiary components? A systematic review and meta-analysis.
Harnden P; Shelley MD; Coles B; Staffurth J; Mason MD
Lancet Oncol; 2007 May; 8(5):411-9. PubMed ID: 17466898
[TBL] [Abstract][Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
